Clinical trial · Observational
Development of the Oncology Opportunity Cost Assessment Tool
Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study develops and tests an instrument to measure opportunity costs called the Oncology Opportunity Cost Assessment Tool (OOCAT) in cancer patients. Patients experience significant costs, both direct financial as well as indirect costs, associated with seeking cancer treatment. While the direct financial impact of care on patients is receiving increased attention, other important consequences, such as opportunity cost, remain largely unmeasured. Opportunity cost is an economics term that refers to the loss of potential benefits from other options when one option is chosen - if resources are used for one purpose, they are no longer available for the next best option. The information and knowledge gained from this study may help researchers develop the OOCAT, which may allow them to understand the opportunity cost of treatment for each patient. The OOCAT may then be used to determine not just the best medications for patients, but also the best comprehensive treatment plan that will allow them to get the right treatment in the right place at the right time.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphoid Cell Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Focus Group | Behavioral | — | UNRESOLVED |
| Interview | Other | — | UNRESOLVED |
| Research or Clinical Assessment Tool | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Health Services Research (focus group, interview, OOCAT)
- description
- FOCUS GROUP: Patients participate in focus group session over 60-90 minutes. COGNITIVE INTERVIEW: Patients complete cognitive interview on the clarity, interpretability, and ease of use of the OOCAT. FEASIBILITY TESTING: Patients receive OOCAT at the point of care, online, or via telephone, per patients' preference.
- interventionNames
- Behavioral: Focus Group
- Other: Interview
- Other: Research or Clinical Assessment Tool
Primary outcomes (3)
- measure
- Patient-level opportunity costs associated with oncology care
- timeFrame
- 1 Day of Interview
- description
- Patient-identified themes that contribute to opportunity cost will be generated via patient focus groups
- measure
- Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Treated for cancer at one of the 3 participating sites (Jefferson Center City, Jefferson Methodist Hospital, Jefferson Abington) * English speaking * Able to attend and participate in a focus group Exclusion Criteria: * Treated at a Jefferson site other than the ones mentioned * Non-English Speaking
References
Publications (0)
Data not yet available